← Back to headlines
Pfizer and Astellas Pharma Announce Positive Results for PADCEVTM Clinical Trial
Pfizer Inc. and Astellas Pharma have announced positive results from their Phase 3 EV-304 clinical trial for the drug PADCEVTM.
1 Mar, 09:27 — 1 Mar, 09:27
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
PH records 701,884 deaths in 2024; nearly half occur outside health facilities
just now
We’re asking the wrong question about exercise – it’s not about what’s best, but what sticks
26m ago
Évora Hospital pioneers AI use to detect cancer
31m ago
Stephanie Buttermore cause of death: What happened to Jeff Nippard's fiancé? Details
49m ago